Ten-year results show a single CAR T infusion can keep many patients with aggressive and slow-growing B-cell lymphomas cancer-free, pointing toward true long-term cures.
A leading-edge immunotherapy may extend survival for patients with one of the most aggressive forms of blood cancer, ...
CAR T-cell therapy, which transforms patients’ own immune cells into cancer-fighting warriors, has revolutionized how physicians treat cancer, especially blood cancers. “These patients can be cured ...
MB-105, a CD5-targeted CAR-T cell therapy, has received FDA regenerative medicine advanced therapy designation for relapsed/refractory CD5-positive T-cell lymphoma. The designation aims to expedite ...
Sam Neill fought stage 3 angioimmunoblastic T-cell lymphoma, a rare type of blood cancer, but found success in treatment with ...
Researchers led by Universitätsmedizin Frankfurt and Goethe University Frankfurt have identified how particularly aggressive forms of lymphoma can be recognized.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results